CYSTAGON

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug CYSTAGON contains one active pharmaceutical ingredient (API):

1 Mercaptamine
UNII QO84GZ3TST - CYSTEAMINE BITARTRATE

Mercaptamine reduces corneal cystine crystal accumulation acting as a cystine-depleting agent by converting cystine to cysteine and cysteine-cysteamine mixed disulfides.

Read about Mercaptamine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CYSTAGON Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
CYSTAGON Capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A16AA04 Mercaptamine A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1200249, 1200250, 1200261, 1200272, 1849620
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 97039001, 97039003
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 419838, 419929, 419937, 419978
Country: FR Base de données publique des médicaments Identifier(s): 64781800, 68718427
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 39800, 39803
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7659
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1028363, 1028364, 1028365, 1028366
Country: NL Z-Index G-Standaard, PRK Identifier(s): 110000, 110019
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100133637, 100133643
Country: US FDA, National Drug Code Identifier(s): 0378-9040, 0378-9045

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.